Abstract
Alcoholic beverages are widely consumed, resulting in a staggering economic cost in different social and cultural settings. Types of alcohol consumption vary from light occasional to heavy, binge drinking, and chronic alcohol abuse at all ages. In general, heavy alcohol consumption is widely recognized as a major epidemiological risk factor for chronic diseases and is detrimental to many organs and tissues, including bones. Indeed, recent findings demonstrate that alcohol has a dose-dependent toxic effect in promoting imbalanced bone remodeling. This imbalance eventually results in osteopenia, an established risk factor for osteoporosis. Decreased bone mass and strength are major hallmarks of osteopenia, which is predominantly attributed not only to inhibition of bone synthesis but also to increased bone resorption through direct and indirect pathways. In this review, we present knowledge to elucidate the epidemiology, potential pathogenesis, and major molecular mechanisms and cellular effects that underlie alcoholism-induced bone loss in osteopenia. Novel therapeutic targets for correcting alcohol-induced osteopenia are also reviewed, such as modulation of proinflammatory cytokines and Wnt and mTOR signaling and the application of new drugs.
Similar content being viewed by others
References
Miranda RC, Pietrzykowski AZ, Tang Y et al (2010) MicroRNAs: master regulators of ethanol abuse and toxicity. Alcohol Clin Exp Res 34:575–587
Chakkalakal DA (2005) Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res 29:2077–2090
Jonsson IM, Verdrengh M, Brisslert M et al (2007) Ethanol prevents development of destructive arthritis. Proc Natl Acad Sci USA 104:258–263
Callaci JJ, Juknelis D, Patwardhan A, Wezeman FH (2006) Binge alcohol treatment increases vertebral bone loss following ovariectomy: compensation by intermittent parathyroid hormone. Alcohol Clin Exp Res 30:665–672
Sampson HW (2002) Alcohol and other factors affecting osteoporosis risk in women. Alcohol Res Health 26:292–298
Turner RT (2000) Skeletal response to alcohol. Alcohol Clin Exp Res 24:1693–1701
Callaci JJ, Himes R, Lauing K, Roper P (2010) Long-term modulations in the vertebral transcriptome of adolescent-stage rats exposed to binge alcohol. Alcohol Alcohol 45:332–346
Dyer SA, Buckendahl P, Sampson HW (1998) Alcohol consumption inhibits osteoblastic cell proliferation and activity in vivo. Alcohol 16:337–341
Turner RT, Sibonga JD (2001) Effects of alcohol use and estrogen on bone. Alcohol Res Health 25:276–281
Duggal S, Simpson ME, Keiver K (2007) Effect of chronic ethanol consumption on the response of parathyroid hormone to hypocalcemia in the pregnant rat. Alcohol Clin Exp Res 31:104–112
Howe KS, Iwaniec UT, Turner RT (2011) The effects of low dose parathyroid hormone on lumbar vertebrae in a rat model for chronic alcohol abuse. Osteoporos Int 22:1175–1181
Wezeman FH, Gong Z (2001) Bone marrow triglyceride accumulation and hormonal changes during long-term alcohol intake in male and female rats. Alcohol Clin Exp Res 25:1515–1522
Dai J, Lin D, Zhang J et al (2000) Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. J Clin Investig 106:887–895
Mercer KE, Wynne RA, Lazarenko OP et al (2012) Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice. J Pharmacol Exp Ther 343:401–412
Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83:1032–1045
Frost M, Wraae K, Gudex C et al (2012) Chronic diseases in elderly men: underreporting and underdiagnosis. Age Ageing 41:177–183
Williams FM, Cherkas LF, Spector TD, MacGregor AJ (2005) The effect of moderate alcohol consumption on bone mineral density: a study of female twins. Ann Rheum Dis 64:309–310
Ganry O, Baudoin C, Fardellone P (2000) Effect of alcohol intake on bone mineral density in elderly women: the EPIDOS study. Am J Epidemiol 151:773–780
McGuire S (2011) U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, January 2011. Adv Nutr 2:293–294
Alvisa-Negrín J, González-Reimers E, Santolaria-Fernández F et al (2009) Osteopenia in alcoholics: effect of alcohol abstinence. Alcohol Alcohol 44:468–475
Audran M, Cortet B (2011) Prevalence of osteoporosis in male patients with risk factors. Presse Med 40:e489–e498
Kizilgul M, Ozcelik O, Delibasi T (2016) Bone health and vitamin D status in alcoholic liver disease. Indian J Gastroenterol 35:253–259
Menecier P, Girard A, Badila P, Rotheval L, Lefranc D, Menecier-Ossia L (2009) Acute alcoholic intoxication at the hospital: a clinical stake. A prospective study of one year in a general hospital. Rev Med Interne 30:316–321
Mikosch P (2014) Alcohol and bone. Wien Med Wochenschr 164:15–24
Shankar K, Hidestrand M, Haley R et al (2006) Different molecular mechanisms underlie ethanol-induced bone loss in cycling and pregnant rats. Endocrinology 147:166–178
Wang Y, Li Y, Mao K, Li J, Cui Q, Wang GJ (2003) Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin Orthop Relat Res 410:213–224
Friday KE, Howard GA (1991) Ethanol inhibits human bone cell proliferation and function in vitro. Metabolism 40:562–565
Jugdaohsingh R, O’Connell MA, Sripanyakorn S, Powell JJ (2006) Moderate alcohol consumption and increased bone mineral density: potential ethanol and non-ethanol mechanisms. Proc Nutr Soc 65:291–310
Høidrup S, Grønbaek M, Gottschau A, Lauritzen JB, Schroll M (1999) Alcohol intake, beverage preference, and risk of hip fracture in men and women. Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 149:993–1001
Torricelli P, Fini M, Giavaresi G et al (2007) Intermittent exposure to ethanol vapor affects osteoblast behaviour more severely than estrogen deficiency does in vitro study on rat osteoblasts. Toxicology 237:168–176
Díez-Ruiz A, García-Saura PL, García-Ruiz P, González-Calvin JL, Gallego-Rojo F, Fuchs D (2010) Bone mineral density, bone turnover markers and cytokines in alcohol-induced cirrhosis. Alcohol Alcohol 45:427–430
Cheung RC, Gray C, Boyde A, Jones SJ (1995) Effects of ethanol on bone cells in vitro resulting in increased resorption. Bone 16:143–147
Yao Z, Zhang J, Dai J, Keller ET (2001) Ethanol activates NFkappaB DNA binding and p56lck protein tyrosine kinase in human osteoblast-like cells. Bone 28:167–173
García-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F et al (2006) Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease. Alcohol Alcohol 41:261–266
Fábrega E, Orive A, García-Suarez C, García-Unzueta M, Antonio AJ, Pons-Romero F (2005) Osteoprotegerin and RANKL in alcoholic liver cirrhosis. Liver Int 25:305–310
Perrien DS, Brown EC, Fletcher TW et al (2002) Interleukin-1 and tumor necrosis factor antagonists attenuate ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis. J Pharmacol Exp Ther 303:904–908
Wahl EC, Aronson J, Liu L et al (2007) Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: role of the TNF signaling axis. Toxicol Appl Pharmacol 220:302–310
Shankar K, Hidestrand M, Liu X et al (2008) Chronic ethanol consumption inhibits postlactational anabolic bone rebuilding in female rats. J Bone Miner Res 23:338–349
Chen JR, Lazarenko OP, Shankar K, Blackburn ML, Badger TM, Ronis MJ (2010) A role for ethanol-induced oxidative stress in controlling lineage commitment of mesenchymal stromal cells through inhibition of Wnt/beta-catenin signaling. J Bone Miner Res 25:1117–1127
Galli C, Passeri G, Macaluso GM (2010) Osteocytes and WNT: the mechanical control of bone formation. J Dent Res 89:331–343
Bonewald LF, Johnson ML (2008) Osteocytes, mechanosensing and Wnt signaling. Bone 42:606–615
Smith C, Gasparetto M, Jordan C, Pollyea DA, Vasiliou V (2015) The effects of alcohol and aldehyde dehydrogenases on disorders of hematopoiesis. Adv Exp Med Biol 815:349–359
Ronis MJ, Mercer K, Chen JR (2011) Effects of nutrition and alcohol consumption on bone loss. Curr Osteoporos Rep 9:53–59
Bianco P, Riminucci M, Gronthos S, Robey PG (2001) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180–192
Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Liu Y, Kou X, Chen C et al (2016) Chronic high dose alcohol induces osteopenia via activation of mTOR signaling in bone marrow mesenchymal stem cells. Stem Cells 34:2157–2168
Yang H, Rudge DG, Koos JD, Vaidialingam B, Yang HJ, Pavletich NP (2013) mTOR kinase structure, mechanism and regulation. Nature 497:217–223
Martin SK, Fitter S, Dutta AK et al (2015) Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation. Stem Cells 33:1359–1365
Dai Q, Xie F, Han Y et al (2017) Inactivation of regulatory-associated protein of mTOR (raptor)/mammalian target of rapamycin complex 1 (mTORC1) signaling in osteoclasts increases bone mass by inhibiting osteoclast differentiation in mice. J Biol Chem 292:196–204
Dorgan JF, Reichman ME, Judd JT et al (1994) The relation of reported alcohol ingestion to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States). Cancer Causes Control 5:53–60
Chen JR, Haley RL, Hidestrand M et al (2006) Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts. J Pharmacol Exp Ther 319:1182–1190
Monroe DG, Getz BJ, Johnsen SA, Riggs BL, Khosla S, Spelsberg TC (2003) Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta. J Cell Biochem 90:315–326
Syed F, Khosla S (2005) Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 328:688–696
Chen JR, Plotkin LI, Aguirre JI et al (2005) Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens. J Biol Chem 280:4632–4638
Bai XC, Lu D, Liu AL et al (2005) Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem 280:17497–17506
Lean JM, Davies JT, Fuller K et al (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Investig 112:915–923
Díez A, Puig J, Serrano S et al (1994) Alcohol-induced bone disease in the absence of severe chronic liver damage. J Bone Miner Res 9:825–831
Malik P, Gasser RW, Kemmler G et al (2009) Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol Clin Exp Res 33:375–381
Swarthout JT, D’Alonzo RC, Selvamurugan N, Partridge NC (2002) Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 282:1–17
Lombardi G, Di SC, Rubino M et al (2011) The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics. J Endocrinol Investig 34:18–22
Anderson PH, Sawyer RK, Moore AJ, May BK, O’Loughlin PD, Morris HA (2008) Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res 23:1789–1797
Baldock PA, Thomas GP, Hodge JM et al (2006) Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast. J Bone Miner Res 21:1618–1626
Lang CH, Frost RA, Summer AD, Vary TC (2005) Molecular mechanisms responsible for alcohol-induced myopathy in skeletal muscle and heart. Int J Biochem Cell Biol 37:2180–2195
Firth SM, Baxter RC (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824–854
Maurel DB, Boisseau N, Benhamou CL, Jaffre C (2012) Alcohol and bone: review of dose effects and mechanisms. Osteoporos Int 23:1–16
Maddalozzo GF, Turner RT, Edwards CH et al (2009) Alcohol alters whole body composition, inhibits bone formation, and increases bone marrow adiposity in rats. Osteoporos Int 20:1529–1538
Lang CH, Fan J, Lipton BP, Potter BJ, McDonough KH (1998) Modulation of the insulin-like growth factor system by chronic alcohol feeding. Alcohol Clin Exp Res 22:823–829
Lang CH, Liu X, Nystrom G, Wu D, Cooney RN, Frost RA (2000) Acute effects of growth hormone in alcohol-fed rats. Alcohol Alcohol 35:148–158
Menagh PJ, Turner RT, Jump DB et al (2010) Growth hormone regulates the balance between bone formation and bone marrow adiposity. J Bone Miner Res 25:757–768
Lang CH, Vary TC, Frost RA (2003) Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1 decreases plasma free IGF-I and muscle protein synthesis. Endocrinology 144:3922–3933
Kumar V, Frost RA, Lang CH (2002) Alcohol impairs insulin and IGF-I stimulation of S6K1 but not 4E-BP1 in skeletal muscle. Am J Physiol Endocrinol Metab 283:E917–E928
Shah OJ, Anthony JC, Kimball SR, Jefferson LS (2000) 4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle. Am J Physiol Endocrinol Metab 279:E715–E729
Ronis MJ, Wands JR, Badger TM, de la Monte SM, Lang CH, Calissendorff J (2007) Alcohol-induced disruption of endocrine signaling. Alcohol Clin Exp Res 31:1269–1285
Bakker AD, Gakes T, Hogervorst JM, de Wit GM, Klein-Nulend J, Jaspers RT (2016) Mechanical stimulation and IGF-1 enhance mRNA translation rate in osteoblasts via activation of the AKT-mTOR pathway. J Cell Physiol 231:1283–1290
Lang CH, Pruznak AM, Deshpande N, Palopoli MM, Frost RA, Vary TC (2004) Alcohol intoxication impairs phosphorylation of S6K1 and S6 in skeletal muscle independently of ethanol metabolism. Alcohol Clin Exp Res 28:1758–1767
Himes R, Wezeman FH, Callaci JJ (2008) Identification of novel bone-specific molecular targets of binge alcohol and ibandronate by transcriptome analysis. Alcohol Clin Exp Res 32:1167–1180
Novitskiy G, Traore K, Wang L, Trush MA, Mezey E (2006) Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells. Alcohol Clin Exp Res 30:1429–1435
Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H (2007) Trends in oxidative aging theories. Free Radic Biol Med 43:477–503
Chen JR, Shankar K, Nagarajan S, Badger TM, Ronis MJ (2008) Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade. J Pharmacol Exp Ther 324:50–59
Serrander L, Cartier L, Bedard K et al (2007) NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406:105–114
Chen JR, Lazarenko OP, Shankar K et al (2011) Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats. J Pharmacol Exp Ther 336:734–742
Schröder K, Wandzioch K, Helmcke I, Brandes RP (2009) Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler Thromb Vasc Biol 29:239–245
Colston JT, de la Rosa SD, Strader JR, Anderson MA, Freeman GL (2005) H2O2 activates Nox4 through PLA2-dependent arachidonic acid production in adult cardiac fibroblasts. FEBS Lett 579:2533–2540
Shankar K, Liu X, Singhal R et al (2008) Chronic ethanol consumption leads to disruption of vitamin D3 homeostasis associated with induction of renal 1,25 dihydroxyvitamin D3-24-hydroxylase (CYP24A1). Endocrinology 149:1748–1756
Torres M (2003) Mitogen-activated protein kinase pathways in redox signaling. Front Biosci 8:d369–d391
O’Brien CA, Gubrij I, Lin SC, Saylors RL, Manolagas SC (1999) STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone. J Biol Chem 274:19301–19308
Wu RF, Ma Z, Myers DP, Terada LS (2007) HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK MAP kinases. J Biol Chem 282:37412–37419
Lee NK, Choi YG, Baik JY et al (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106:852–859
Thakur V, Pritchard MT, McMullen MR, Wang Q, Nagy LE (2006) Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukoc Biol 79:1348–1356
Yeh CH, Chang JK, Wang YH, Ho ML, Wang GJ (2008) Ethanol may suppress Wnt/beta-catenin signaling on human bone marrow stroma cells: a preliminary study. Clin Orthop Relat Res 466:1047–1053
Marie PJ (2015) Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies. Cell Mol Life Sci 72:1347–1361
Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:179–192
Paszty C, Turner CH, Robinson MK (2010) Sclerostin: a gem from the genome leads to bone-building antibodies. J Bone Miner Res 25:1897–1904
van Bezooijen RL, ten Dijke P, Papapoulos SE, Löwik CW (2005) SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev 16:319–327
González-Reimers E, Quintero-Platt G, Rodríguez-Rodríguez E, Martínez-Riera A, Alvisa-Negrín J, Santolaria-Fernández F (2015) Bone changes in alcoholic liver disease. World J Hepatol 7:1258–1264
Cummings SR, San MJ, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765
Li J, Kim SG, Blenis J (2014) Rapamycin: one drug, many effects. Cell Metab 19:373–379
Shaw RJ, Bardeesy N, Manning BD et al (2004) The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6:91–99
Abraham RT, Wiederrecht GJ (1996) Immunopharmacology of rapamycin. Annu Rev Immunol 14:483–510
Mukhopadhyay S, Frias MA, Chatterjee A, Yellen P, Foster DA (2016) The enigma of rapamycin dosage. Mol Cancer Ther 15:347–353
Wezeman FH, Juknelis D, Himes R, Callaci JJ (2007) Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats. Bone 41:639–645
López-Larramona G, Lucendo AJ, González-Delgado L (2013) Alcoholic liver disease and changes in bone mineral density. Rev Esp Enferm Dig 105:609–621
Wezeman FH, Emanuele MA, Moskal SF, Steiner J, Lapaglia N (2000) Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat. J Bone Miner Res 15:2033–2041
Rudic JS, Giljaca V, Krstic MN, Bjelakovic G, Gluud C (2011) Bisphosphonates for osteoporosis in primary biliary cirrhosis. Cochrane Database Syst Rev 12:CD009144
Kouda K, Iki M, Fujita Y et al (2011) Alcohol intake and bone status in elderly Japanese men: baseline data from the Fujiwara-kyo osteoporosis risk in men (FORMEN) study. Bone 49:275–280
Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12:21–35
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luo, Z., Liu, Y., Liu, Y. et al. Cellular and molecular mechanisms of alcohol-induced osteopenia. Cell. Mol. Life Sci. 74, 4443–4453 (2017). https://doi.org/10.1007/s00018-017-2585-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-017-2585-y